Two history lessons- the first on 50 years of ... - CLL Support

CLL Support

22,532 members38,709 posts

Two history lessons- the first on 50 years of treating CLL and the 2nd on cellular therapies including transplant and CAR-T

bkoffman profile image
bkoffmanCLL CURE Hero
3 Replies

Last week we published an interview with Prof. Hoffbrand cllsociety.org/2019/07/ash-... that offers a remarkable overview of CLL treatment over 1/2 a century and also the history and much more on cellular therapies including CAR-T by Dr. Mukherjee, the Pulitzer Prize winning author: cllsociety.org/2019/07/impo...

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
3 Replies
AussieNeil profile image
AussieNeilPartnerFounder Admin

Great interview with Prof. Hoffbrand with some much appreciated CLL history. I knew Chlorambucil/Leukeran was an old drug, but first synthesized in 1953? That's older than many of us in this community!

LynnB1947 profile image
LynnB1947

Can't wait to read/listen to this when I'm home with my laptop instead of being in a coffee shop with my tablet. Thanks Dr Brian!

LynnB

Jm954 profile image
Jm954Administrator

Prof Hoffbrand is a legend of Haematology and I used his books, especially Postgraduate Haematology and Essential Haematology throughout the 40+ years of my haematology career. I still have all my old copies.

As a manager, when new staff started I gave them a copy of his book Postgraduate Haematology to keep, it's still the bible of haematology.

The latest version of Essential Haematology is written with Prof Paul Moss, a leading UK CLL researcher based in Birmingham.

Jackie

You may also like...

Tuesday! Nov. 17th CLL Society Webinar \"The Future of CAR-T Therapy: Can CAR-T Cure CLL?”

60-minute webinar....

Starting CAR-T therapy for my relapsing CLL

months on a new CAR-T section of the website...

My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.

data that emerged from ASH 2018. See: https://cllsociety.org/2019/03/ash-2018-dr-siddiqi-on-the-prac

The current status and challenges of CAR-T therapy in CLL

with these agents in patients with chronic lymphocytic leukemia (CLL).\\" It's a Podcast, so...

CLL Society/ CAR-T! Read the story of Dr. Brian Koffman's 3 years of durable remission post-CAR-T!

years of durable remission here. https://cllsociety.org/2021/03/car-t-three-years-later-dr-brian-kof